HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Petro Selected Research

Daniel Petro Research Topics

Disease

3Neoplasms (Cancer)
10/2019 - 12/2010
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2022
1Dermatitis
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Lung Neoplasms (Lung Cancer)
10/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2011
1Disease Progression
12/2010
1Diarrhea
12/2010
1Fatigue
12/2010
1Infections
12/2010
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2010
1Neutropenia
12/2010
1Acute Kidney Injury (Acute Renal Failure)
12/2010
1Pneumonia (Pneumonitis)
12/2010
1Thrombocytopenia (Thrombopenia)
12/2010

Drug/Important Bio-Agent (IBA)

1IpilimumabIBA
01/2022
1SteroidsIBA
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1palbociclibIBA
10/2019
1PlatinumIBA
10/2019
1Cyclin-Dependent Kinase 4IBA
10/2019
1Cyclin D2IBA
10/2019
1Cyclin D3IBA
10/2019
1GemcitabineFDA Link
09/2017
1veliparibIBA
09/2017
1Carboplatin (JM8)FDA LinkGeneric
03/2011
1Paclitaxel (Taxol)FDA LinkGeneric
03/2011
1Liposomes (Liposome)IBA
03/2011
1Superoxide DismutaseIBA
03/2011
1Biomarkers (Surrogate Marker)IBA
12/2010
1TOR Serine-Threonine KinasesIBA
12/2010
1Transaminases (Aminotransferases)IBA
12/2010
1EverolimusFDA Link
12/2010

Therapy/Procedure

3Drug Therapy (Chemotherapy)
10/2019 - 03/2011
2Radiotherapy
01/2022 - 03/2011